• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Expensify And 2 Other Penny Stocks Insiders Are Buying

    7/11/24 9:13:05 AM ET
    $CYAN
    $DOUG
    $EXFY
    Medicinal Chemicals and Botanical Products
    Health Care
    Real Estate
    Finance
    Get the next $CYAN alert in real time by email

    The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

    Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

    Expensify

    • The Trade: Expensify, Inc. (NASDAQ:EXFY) 10% owner SF Roofdeck GP LLC bought a total of 123,217 shares at an average price of $1.45. To acquire these shares, it cost around $178,665.
    • What's Happening: On June 14, JMP Securities analyst Joe Goodwin reiterated Expensify with a Market Perform.
    • What Expensify Does: Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money.

    Cyanotech

    • The Trade: Cyanotech Corporation (OTC:CYAN) Director Michael A / Davis acquired a total of 10,000 shares at an average price of $0.36. To acquire these shares, it cost around $3,550.
    • What's Happening: On June 26, Cyanotech reported net sales of $23,071,000 for fiscal 2024 compared to $23,178,000 in fiscal 2023.
    • What Cyanotech Does: Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market.

    Douglas Elliman

    • The Trade: Douglas Elliman Inc (NYSE:DOUG) Director, Chairman, President & CEO Howard M Lorber acquired a total of 100,000 shares at an average price of $1.15. The insider spent around $114,563 to buy those shares. The company's Director Mark Zeitchick also bought 112,750 shares of the company.
    • What's Happening: On July 2, Douglas Elliman announced that it secured a $50 million growth investment from Kennedy Lewis Investment Management.
    • What Douglas Elliman Does: Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate.

    Read Next:

    • Wall Street’s Most Accurate Analysts Weigh In On 3 Consumer Stocks Delivering High-Dividend Yields
    Get the next $CYAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CYAN
    $DOUG
    $EXFY

    CompanyDatePrice TargetRatingAnalyst
    Expensify Inc.
    $EXFY
    8/8/2025$3.00 → $2.50Market Perform
    BMO Capital Markets
    Expensify Inc.
    $EXFY
    11/25/2024Mkt Outperform → Mkt Perform
    JMP Securities
    Expensify Inc.
    $EXFY
    8/9/2024$2.50Mkt Perform → Mkt Outperform
    JMP Securities
    Expensify Inc.
    $EXFY
    5/28/2024Underweight → Equal-Weight
    Morgan Stanley
    Expensify Inc.
    $EXFY
    9/15/2023Underweight
    JP Morgan
    Expensify Inc.
    $EXFY
    8/9/2023Mkt Outperform → Mkt Perform
    JMP Securities
    Expensify Inc.
    $EXFY
    8/9/2023$9.00 → $6.00Buy → Hold
    Loop Capital
    Douglas Elliman Inc.
    $DOUG
    7/18/2023Neutral
    BTIG Research
    More analyst ratings

    $CYAN
    $DOUG
    $EXFY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Expensify and Xero Enhance Partnership to Support Small Businesses

    The new partnership offers customers Xero for free for six months and six months of Expensify for 50% off. Expensify, Inc. (NASDAQ:EXFY), the easiest way to manage expenses, corporate cards, and travel, today announced an expanded partnership with Xero, a global leader in cloud-based accounting software, to deliver exclusive discounts and joint marketing campaigns that simplify operations for small businesses. The collaboration enhances the relationship between two of the most trusted platforms in spend management and accounting, offering new customers significant savings and increased visibility into industry-leading integration options across both ecosystems. "This partnership is ab

    2/12/26 9:00:00 AM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    Expensify to Announce Q4 and Full Year 2025 Results

    Join Expensify's earnings call on Thursday, February 26th at 2pm PT / 5pm ET. Expensify, Inc. (NASDAQ:EXFY), the easiest way to manage expenses, corporate cards, and travel, today announced that the company's Q4 and full year 2025 financial results will be released after market close on Thursday, February 26th, 2026. Expensify will host a call to discuss its Q4 and full year fiscal 2025 results on Thursday, February 26th, 2026 at 2pm PT / 5pm ET. The link to the call will be available that day on the company's Investor Relations website at investors.expensify.com. Prior to the call, interested parties can visit the website to add the event to their calendars. After the call, the follo

    2/12/26 9:00:00 AM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    Douglas Elliman Expands In-House Mortgage Platform Elliman Capital to New York

    Leading luxury real estate brokerage brings comprehensive financing solution for traditional and non-traditional borrowers to its flagship market NEW YORK, Jan. 7, 2026 /PRNewswire/ -- Douglas Elliman Real Estate, the nation's leading luxury residential real estate brokerage, today announced that Elliman Capital, the innovative in-house mortgage platform launched last July in Florida, has now expanded to New York, which includes all of New York City, Long Island, the Hamptons, North Fork, Westchester and Hudson Valley. Powered by a strategic alliance with Associated Mortgage Bankers, Elliman Capital provides a seamless, full-service lending solution with a wide array of financing options—inc

    1/7/26 2:00:00 PM ET
    $DOUG
    Real Estate
    Finance

    $CYAN
    $DOUG
    $EXFY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Christen Timothy L bought $57,200 worth of shares (40,000 units at $1.43), increasing direct ownership by 16% to 289,754 units (SEC Form 4)

    4 - Expensify, Inc. (0001476840) (Issuer)

    11/13/25 5:52:23 PM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    Director Bartels Patrick J Jr bought $253,682 worth of shares (135,000 units at $1.88), increasing direct ownership by 229% to 193,975 units (SEC Form 4)

    4 - Douglas Elliman Inc. (0001878897) (Issuer)

    5/12/25 5:25:05 PM ET
    $DOUG
    Real Estate
    Finance

    Officer Liebowitz Michael bought $1,816,776 worth of shares (1,081,414 units at $1.68) (SEC Form 4)

    4 - Douglas Elliman Inc. (0001878897) (Issuer)

    11/19/24 8:45:05 AM ET
    $DOUG
    Real Estate
    Finance

    $CYAN
    $DOUG
    $EXFY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Expensify with a new price target

    BMO Capital Markets reiterated coverage of Expensify with a rating of Market Perform and set a new price target of $2.50 from $3.00 previously

    8/8/25 7:50:56 AM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    Expensify downgraded by JMP Securities

    JMP Securities downgraded Expensify from Mkt Outperform to Mkt Perform

    11/25/24 7:42:36 AM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    Expensify upgraded by JMP Securities with a new price target

    JMP Securities upgraded Expensify from Mkt Perform to Mkt Outperform and set a new price target of $2.50

    8/9/24 7:28:58 AM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    $CYAN
    $DOUG
    $EXFY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Liu Ying was granted 3,386 shares, increasing direct ownership by 2% to 174,093 units (SEC Form 4)

    4 - Expensify, Inc. (0001476840) (Issuer)

    2/18/26 6:09:21 PM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Barrett David Michael sold $43,500 worth of shares (30,000 units at $1.45) (SEC Form 4)

    4 - Expensify, Inc. (0001476840) (Issuer)

    2/4/26 6:10:01 PM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    Director Alvarez Divo Carlos Eduardo sold $13,507 worth of shares (8,972 units at $1.51) and disposed of 33,592 shares, decreasing direct ownership by 13% to 285,508 units (SEC Form 4)

    4 - Expensify, Inc. (0001476840) (Issuer)

    1/12/26 6:14:02 PM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    $CYAN
    $DOUG
    $EXFY
    SEC Filings

    View All

    SEC Form 15-12G filed by Cyanotech Corporation

    15-12G - CYANOTECH CORP (0000768408) (Filer)

    2/13/26 2:42:59 PM ET
    $CYAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13E3/A filed by Cyanotech Corporation

    SC 13E3/A - CYANOTECH CORP (0000768408) (Subject)

    2/13/26 2:09:31 PM ET
    $CYAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13E3/A filed by Cyanotech Corporation

    SC 13E3/A - CYANOTECH CORP (0000768408) (Subject)

    2/3/26 5:18:38 PM ET
    $CYAN
    Medicinal Chemicals and Botanical Products
    Health Care

    $CYAN
    $DOUG
    $EXFY
    Leadership Updates

    Live Leadership Updates

    View All

    Douglas Elliman Appoints Natalie Passerini as Chief Marketing Officer

    Creative Marketing Leader Returns to Premiere Luxury Brokerage Amid Major Rebranding Initiative NEW YORK, Dec. 18, 2025 /PRNewswire/ -- Douglas Elliman Realty, the nation's leading luxury real estate brokerage, today announced that Natalie Passerini has joined the company as Chief Marketing Officer. Having served previously as the firm's Vice President of Marketing, Passerini returns as Elliman enters a pivotal period of brand evolution focused on elevating agent visibility, strengthening market leadership, and positioning the brand for long-term growth. She will oversee the strategic leadership of Douglas Elliman's corporate brand and fully integrated national marketing platform. Her mandat

    12/18/25 9:00:00 AM ET
    $DOUG
    Real Estate
    Finance

    Douglas Elliman Real Estate Appoints Wendy Purvey as Chief Strategy Officer

    A 30-year-plus industry veteran, Purvey will spearhead strategic initiatives to fuel the company's long-term growth and drive revenue generation. NEW YORK, Nov. 12, 2025 /PRNewswire/ -- Douglas Elliman Realty, LLC ("Douglas Elliman"), one of the largest residential real estate brokerages in the country with the highest national average sales price, announced today that it has appointed Wendy S. Purvey to the role of Chief Strategy Officer. In this new role, Purvey will spearhead growth and revenue-generation initiatives, including supporting mergers and acquisitions, international partnerships, launching ancillary services opportunities, and optimizing agent retention.

    11/12/25 4:00:00 PM ET
    $DOUG
    Real Estate
    Finance

    Douglas Elliman Real Estate Names Chris Reyes Chief Technology Officer

    NEW YORK, Nov. 11, 2025 /PRNewswire/ -- Douglas Elliman Realty, LLC ("Douglas Elliman"), one of the largest independent residential real estate brokerages in the United States, today announced the appointment of Chris Reyes as Chief Technology Officer. Mr. Reyes joins Douglas Elliman from Brown Harris Stevens where he served as CTO. In his new role, Reyes will oversee Douglas Elliman's technology team, infrastructure, product launch, and software development across all regions nationally. He brings more than two decades of experience innovating enterprise platforms and service

    11/11/25 11:00:00 AM ET
    $DOUG
    Real Estate
    Finance

    $CYAN
    $DOUG
    $EXFY
    Financials

    Live finance-specific insights

    View All

    Expensify to Announce Q4 and Full Year 2025 Results

    Join Expensify's earnings call on Thursday, February 26th at 2pm PT / 5pm ET. Expensify, Inc. (NASDAQ:EXFY), the easiest way to manage expenses, corporate cards, and travel, today announced that the company's Q4 and full year 2025 financial results will be released after market close on Thursday, February 26th, 2026. Expensify will host a call to discuss its Q4 and full year fiscal 2025 results on Thursday, February 26th, 2026 at 2pm PT / 5pm ET. The link to the call will be available that day on the company's Investor Relations website at investors.expensify.com. Prior to the call, interested parties can visit the website to add the event to their calendars. After the call, the follo

    2/12/26 9:00:00 AM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    Cyanotech Reports Financial Results for the Second Quarter of Fiscal 2026

    Cyanotech Corporation (OTCQB:CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter of fiscal year 2026, ended September 30, 2025. Commenting on the second quarter of fiscal year 2026 results, Cyanotech's President and Chief Executive Officer, Matthew K. Custer, said: "Our second quarter reflected continued momentum in both sales growth and profitability. Total sales increased 19.3% year-over-year, driven by higher bulk sales and strong performance in our online channels. "We also saw meaningful improvement in gross margin as our production volumes continued to increase, driving lower per

    11/10/25 8:00:00 AM ET
    $CYAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Expensify Announces Q3 2025 Results

    Total interchange derived from the Expensify Card grew to $5.4 million, an increase of 18% as compared to the same period last year. Expensify, Inc. (NASDAQ:EXFY), the easiest way to manage expenses, corporate cards, and travel, today released a letter to shareholders from Founder and CEO David Barrett alongside results for its quarter ended September 30, 2025. A Message From Our Founder Expensify continues to generate free cash flow, grow interchange (up 18% y/y), and grow travel bookings (up 95% since Q1). We're standing by our FY'25 free cash flow guidance of $19.0 million to $23.0 million, and have announced that Expensify is the Official Travel and Expense partner of the Brooklyn Ne

    11/6/25 4:00:00 PM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    $CYAN
    $DOUG
    $EXFY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Expensify Inc.

    SC 13G/A - Expensify, Inc. (0001476840) (Subject)

    11/20/24 5:30:35 PM ET
    $EXFY
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Douglas Elliman Inc.

    SC 13D/A - Douglas Elliman Inc. (0001878897) (Subject)

    10/23/24 5:16:48 PM ET
    $DOUG
    Real Estate
    Finance

    Amendment: SEC Form SC 13D/A filed by Cyanotech Corporation

    SC 13D/A - CYANOTECH CORP (0000768408) (Subject)

    10/3/24 6:39:03 PM ET
    $CYAN
    Medicinal Chemicals and Botanical Products
    Health Care